Autor: |
Nieto JE; Department of Immunology and Research Unit, Institute of Ophthalmology 'Conde de Valenciana Foundation', Ciudad de México 06800, Mexico., Casanova I; Department of Immunology and Research Unit, Institute of Ophthalmology 'Conde de Valenciana Foundation', Ciudad de México 06800, Mexico., Serna-Ojeda JC; Department of Cornea and Refractive Surgery, Institute of Ophthalmology 'Conde de Valenciana Foundation', Ciudad de México 06800, Mexico., Graue-Hernández EO; Department of Cornea and Refractive Surgery, Institute of Ophthalmology 'Conde de Valenciana Foundation', Ciudad de México 06800, Mexico., Quintana G; Department of Immunology and Research Unit, Institute of Ophthalmology 'Conde de Valenciana Foundation', Ciudad de México 06800, Mexico., Salazar A; Department of Immunology and Research Unit, Institute of Ophthalmology 'Conde de Valenciana Foundation', Ciudad de México 06800, Mexico., Jiménez-Martinez MC; Department of Immunology and Research Unit, Institute of Ophthalmology 'Conde de Valenciana Foundation', Ciudad de México 06800, Mexico.; Department of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico, Ciudad de México 04510, Mexico. |
Abstrakt: |
Ocular allergic diseases are frequently seen in ophthalmological clinical practice. Immunological damage is mediated by a local Th2 inflammatory microenvironment, accompanied by changes in circulating cell subsets, with more effector cells and fewer T regulatory cells (Tregs). This study aimed to evaluate the involvement of toll-like receptor 4 (TLR4) and α-melanocyte stimulating hormone (α-MSH) in the immune regulation associated with perennial allergic conjunctivitis (PAC). We performed an Ag-specific stimulation during 72 h of culturing with or without lipopolysaccharide (LPS) or α-MSH in peripheral blood mononuclear cells (PBMC), analyzing the cell subsets and cytokines induced by the stimuli. We also determined α-MSH in tear samples from healthy donors (HD) or PAC patients. Our findings demonstrate an immunological dysregulation characterized by an increased frequency of CD4+TLR4+ in the PBMC of patients with PAC, compared to HD. Most of these CD4+TLR4+ cells were also CD25+, and when α-MSH was added to the culture, the percentage of CD4+CD25+FoxP3+ increased significantly, while the percentage of CD69+ cells and cytokines IL-4 and IL-6 were significantly decreased. In tears, we found an increased concentration of α-MSH in PAC patients, compared with HD. These findings indicate a novel mechanism involved in controlling ocular allergic diseases, in which α-MSH diminishes the concentration of IL-6 and IL-4, restoring the frequency of Tregs and down-regulating CD4 activation. Moreover, we demonstrated the involvement of CD4+TLR4+ cells as an effector cell subset in ocular allergy. |